FDA Inspection 981364 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629223

The FDA completed an inspection of Oklahoma Blood Institute on August 2, 2016 in Hot Springs, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 2, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hot Springs, AR (United States)